pancuronium has been researched along with Leukemia--Myeloid--Acute* in 1 studies
1 other study(ies) available for pancuronium and Leukemia--Myeloid--Acute
Article | Year |
---|---|
[Prolonged neuromuscular damage following corticosteroids and muscle relaxants].
Many patients mechanically ventilated for acute respiratory failure, are treated with medication that includes a combination of cortico-steroids and non-depolarizing neuromuscular-blocking agents (NNBa). A third of them can be expected to develop delayed neuromuscular damage, which may be severe and prolonged. We describe a 50-year-old man who suffered from acute myeloid leukemia and was ventilated due to pneumonia. He was treated with pancuronium and cortico-steroids, and during recovery suffered quadriparesis that lasted several months. Typically this damage is purely motor and is accompanied by absent tendon-reflexes, sometimes with elevated creatine-kinase. Muscle biopsy usually shows deletion and degeneration of thick myosin filaments. The phenomenon is related to the duration of NNBa treatment, and probably results from an adverse synergistic effect on muscle tissue of the cortico-steroids and cortico-steroid-like NNBa given the immobilized patient. Awareness of this adverse effect of steroids and pancuronium, the use of passive mobilization, shortening the use of NNBa and early rehabilitation would minimize disability due to this phenomenon. Topics: Adrenal Cortex Hormones; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Neuromuscular Nondepolarizing Agents; Pancuronium; Paralysis; Pneumonia; Reflex; Respiration, Artificial; Tendons | 2000 |